CTRI/2017/10/010263RecruitingPhase 1
Evaluation of bone morphology following micro-osteoperforations and corticotomy in orthodontic treatment â?? A CBCT analysis - NI
I0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Full set of teeth including second molar should be present with no history of periodontal disease
- •Pre-treatment patients indicated for premolar extractions and periodontally accelerated orthodontic surgeries for the correction of malocclusion will be included in the study
Exclusion Criteria
- •Fracture or severe attrition of teeth will be excluded
- •Individuals with periodontal destruction
- •Subjects with any severe craniofacial disorder such as cleft palate
- •Patients on anti- inflammatory drugs
- •Patients with habit of smoking
- •Patients with uncontrolled systemic disease or periodontal disease were excluded
Investigators
Similar Trials
Active, not recruiting
Phase 1
A Non-invasive Evaluation of Bone Microarchitecture Modification in Osteopenic Postmenopausal Women by 3D Peripheral Quantitative Computed Tomography: A 12 Month, Multicenter, Double-blind, Randomized, Parallel Group Study Comparing Weekly Oral Risedronate 35 mg and PlaceboOsteoporosis is a systemic skeletal disorder characterized by low bone mass and micro-architectural deterioration of bone tissue leading to enhanced bone fragility and susceptibility to fracture. Postmenopausal women with a diagnosis of osteopenia (T score between –2.5 and –1.0 based on the World Health Organization classification) may also be at risk of fracture.MedDRA version: 7.0 Level: PT Classification code 10031285EUCTR2005-003033-41-GBProcter & Gamble Technical Centres Limited156
Active, not recruiting
Not Applicable
A Non-invasive Evaluation of Bone Microarchitecture Modification in Osteopenic Postmenopausal Women by 3D Peripheral Quantitative Computed Tomography: A 12 Month, Multicenter, Double-blind, Randomized, Parallel Group Study Comparing Weekly Oral Risedronate 35 mg and PlaceboEUCTR2005-003033-41-DEProcter & Gamble Technical Centres Limited156
Recruiting
Phase 4
ongitudinal analysis of bone microstructural changes under luseogliflozin treatment using second-generation High-Resolution peripheral Quantitative Computed Tomography (HR-pQCT) in elderly patients with type 2 diabetestype 2 diabetesJPRN-UMIN000036202agasaki University Hospital24
Active, not recruiting
Phase 1
Changes in the bone after a tooth extraction and filling the space with a product obtained from the patient's blood (L-PRF) against the conventional treatmentRegenerative potential of L-PRFEUCTR2017-001068-39-ESOMEQUI40
Completed
Not Applicable
Tomographic and Histologic Assessment on the Influence of the Use of a Collagen Membrane to Protect the Antrostomy After Maxillary Sinus Floor Augmentation.Alveolar Bone LossAlveolar Bone ResorptionNCT03899688ARDEC Academy20